Dipyrone and agranulocytosis: what is the risk?
Edwards
Jayne E
JE
Pain Research and Nuffield Department of Anaesthetics, University of Oxford, Oxford Radcliffe Hospital NHS Trust, The Churchill, OX3 7LJ, Oxford, UK. jayne.edwards@pru.oxa.c.uk
McQuay
Henry J
HJ
D000380:Agranulocytosis / Q000139:chemically induced*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004177:Dipyrone / Q000009:adverse effects*; D006801:Humans; D012306:Risk
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004177:Dipyrone